top of page
  • infomaster

High-Tech Technology Development Commercialization Fund

Celltium Inc. has been selected for the Korea Venture Investment High-Tech Technology Development Commercialization Fund and secured an investment of 1.5 billion won. This investment is planned to be used for the research and development of Charcot-Marie-Tooth disease treatment.

2 views0 comments

Recent Posts

See All

Completion of Animal Experiment Facility Registration

Celltium Corporation has established animal breeding management and animal experiment facilities within its corporate-affiliated research institute and completed registration as an animal experiment f

Comentários


bottom of page